Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Melatonin  COVID-19 treatment studies for Melatonin  C19 studies: Melatonin  Melatonin   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
Efficacy of Melatonin in the Treatment of Patients With COVID-19: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Lan et al., Journal of Medical Virology, doi:10.1002/jmv.27595
Lan et al., Efficacy of Melatonin in the Treatment of Patients With COVID-19: A Systematic Review and Meta-Analysis of.., Journal of Medical Virology, doi:10.1002/jmv.27595
Jan 2022   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Systematic review and meta analysis including 3 of the 5 melatonin RCTs at the time, showing significantly higher recovery with treatment, and lower ICU admission and mortality without statistical significance. The analysis only includes trials before 9/11/21. Adding Hasan (October 2021) results in statistically significant lower mortality.
Currently there are 18 melatonin studies and meta analysis shows:
OutcomeImprovement
Mortality48% lower [27‑63%]
Ventilation29% lower [14‑40%]
ICU admission6% lower [-4‑15%]
Hospitalization19% lower [-9‑40%]
Cases38% fewer [-6‑64%]
Lan et al., 14 Jan 2022, peer-reviewed, 6 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperMelatoninAll
Abstract: Chih-Cheng Lai ORCID iD: 0000-0002-6334-2388 Efficacy of Melatonin in the Treatment of Patients With COVID-19: A Systematic Review and Meta-Analysis of Accepted Article Randomized Controlled Trials Shao-Huan Lan,1,# Hong-Zin Lee,2,# Chien-Ming Chao,3, # Shen-Peng Chang,4 Li-Chin Lu,5 Chih-Cheng Lai6,* 1 School of Pharmaceutical Sciences and Medical Technology, Putian University, Putian 351100, China. shawnlan0713@gmail.com 2 School of Pharmacy, China Medical University, Taichung. hong@mial.cou.edu.tw 3 Department of Intensive Care Medicine, Chi Mei Medical Center, Liouying, Taiwan. ccm870958@yahoo.com.tw 4 Yijia Pharmacy, Tainan 70846, Taiwan. httremoon@ms.szmc.edu.tw 5 School of Management, Putian University, Putian 351100, China. jane90467@gmail.com 6 Department of Internal Medicine, Kaohsiung Veterans General Hospital, Tainan Branch, Tainan, Taiwan. dtmed141@gmail.com # The two authors contributed equally This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1002/jmv.27595. This article is protected by copyright. All rights reserved. *Corresponding author: Dr. Chih-Cheng Lai, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Tainan Branch, Tainan, Taiwan. Accepted Article dtmed141@gmail.com Abstract This study investigated the effect of melatonin on clinical outcomes in patients with COVID-19. We searched PubMed, the Web of Science, the Cochrane Library, Ovid MEDLINE, and Clinicaltrials.gov for randomized controlled trials (RCTs) published before September 11, 2021. Only RCTs that compared the clinical efficacy of melatonin with a placebo in the treatment of patients with COVID-19 was included. The primary outcome measure was the clinical recovery rate. We included 3 RCTs in this meta-analysis. Melatonin 3 mg thrice daily was administered in one RCT, and 3 or 6 mg daily before bedtime in other two trials. Treatment duration was 14 days in two RCTs and 7 days in one trial. The clinical recovery rates were 94.2% (81/86) and 82.4% (70/85) in the melatonin and control groups, respectively. Overall, patients receiving melatonin had a higher clinical recovery rate than did the controls (odds ratio [OR], 3.67; 95% CI, 1.21-11.12; I2 = 0%, P = .02). The risk of intensive care unit admission was numerically lower in the melatonin group than in the control group (8.3% [6/72] vs 17.6% [12/68], OR, 0.45; 95% CI, 0.16-1.25; I2 = 0%, P = .13), and the risk of mortality was numerically lower in the melatonin group than in the control group (1.4% [1/72] vs 4.4% [3/68], OR, 0.32; 95% CI, 0.03-3.18; I2 = 0%, P = .33). In conclusion, melatonin may help improve the clinical outcomes of patients with COVID-19. Keywords: COVID-19, melatonin, outcome, SARS-CoV-2 Highlight  This study investigated the effect of melatonin on clinical outcomes in patients with COVID-19.  Patients receiving melatonin had a higher clinical recovery rate than did the controls (odds ratio [OR], 3.67; 95% CI, 1.21-11.12; I2 = 0%, P = .02).  The risk of intensive care unit admission was only insignificantly lower in This article is protected by copyright. All rights reserved. the melatonin group than in the control group  The risk of mortality was insignificantly lower in the..
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit